The following trials provide information to treat various types of cardiovascular diseases, both for ongoing and completed clinical trials. For more information on this therapy area please click here.
-
expand
A phase IV, 6-week, randomised, double-blind, multicentre, parallel group, comparative study to evaluate the efficacy of rosuvastatin 5mg and atorvastatin 10mg in UK Asian subjects with primary hypercholesterolaemia.
- Study Id
- D3560L00060
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- SHUKRA
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A 6-week, randomised, open-label, parallel group, multi-centre study to compare the efficacy of rosuvastain 10mg with atorvastatin 10mg in the treatment of non-diabetic metabolic syndrome subjects with raised LDL-C
- Study Id
- D3560L00053
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- KREST
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A randomised, double-blind, parallel-group, multicentre study comparing the efficacy of rosuvastatin 10 mg (with a possible titration to 40 mg) with atorvastatin 20 mg (with a possible titration to 80 mg) when given for a period of 16 weeks to subjects with coronary heart disease and a previously performed percutaneous coronary intervention
- Study Id
- D3560L00039
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- D3560L00039
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
An open-label, randomised, multi-centre, phase IIIb/IV, parallel group study to compare the efficacy and safety of rosuvastatin and atorvastatin in subjects with type IIa and IIb hypercholesterolaemia (DISCOVERY)
- Study Id
- D3560L00009
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- DISCOVERY-Asia
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
- Study Id
- D3560L00008
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- D3560L00008
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Effect of an Internet based compliance enhancement tool in subjects with hypercholesterolemia
- Study Id
- D3560L00002
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- D3560L00002
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Effects of a twelve months ROSUVASTATIN treatment plus additional care (drug intake adherence and lifestyle enhancing initiatives ) compared to ROSUVASTATIN treatment alone on long-term disease-related costs in patients with an indication for statin treatment according to the Joint European Guidelines
- Study Id
- D3560L00001
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- ORBITAL
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
Randomized, Double-Blind, multicenter, trial to assess the effect of high & Low doses of ZD4522 on progression of Carotid Artery Atheroma in moderately Hypercholesterolemic subjects with Asymptomatic Carotid Stenosis after 24 months of dosing.
- Study Id
- D3560C00004
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- D3560C00004
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A phase I, open-label, pharmacokinetic study measuring plasma exposure of a 20 mg single dose administration of rosuvastatin calcium to healthy Asian subjects living in the United States related to the pharmacokinetic data obtained from a Caucasian control group
- Study Id
- D3560C00001
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- D3560C00001
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
-
expand
A randomized, open-label, 2 way crossover study to assess the reciprocal effects of co-administration of rosuvastatin 40 mg and ezetimibe 10 mg on the steady-state pharmacokinetics of each drug
- Study Id
- 4522IL/0108
- Disease
- hypercholesterolaemia, diabetes type 2, dyslipidaemia
- Drug Name
- Crestor
- Study Name
- 4522IL/0108
- Recruiting Status
- Unknown
- Protocol Status
- Not Available
- Report Status
- Not Available
